Special Issue "Invertebrate or Macroalgae-Associated Microbiome: A New Source of Bioactive Compounds with Therapeutical, Biotechnological Applications"

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (15 November 2020).

Special Issue Editor

Prof. Dr. Nathalie Bourgougnon
Guest Editor
Laboratoire de Biotechnologie et Chimie Marines, Université Bretagne Sud, France
Interests: phycology, marine molecules, extraction eco-friendly processes, antiviral agents, SAR studies
Special Issues and Collections in MDPI journals

Special Issue Information

Dear Colleagues,

Surfaces immersed in the marine environment are rapidly colonised by bacteria and then by other micro-organisms (fungi, viruses, archaea and microalgae), leading to the formation of diverse, complex, three-dimensional structures called biofilms. Macroalgae and invertebrates such as tunicates, cnidarians, bryozoans, and sponges are no exception to this phenomenon. Since they are fixed, they present complex surface communities of epibiotic micro-organisms. The host microbiota, or ″holobiont″, rich in chemical, physical and biological interactions, regulates the relations between the basibiont and its epibionts. Ranging from mutualistic to commensal and parasitic, the microbiota can be fundamental or detrimental to the functioning of the host. It is now known that many of the bioactive compounds previously attributed to some invertebrates or macroalgae were in fact produced or metabolized by their associated micro-organisms. Environmental stress in an increasingly changing ocean may disturb these complex mutualistic relations.

This Special Issue focuses on new information from present research on macroalgae or invertebrate‐associated microbiota (bacteria, fungi, virus) as interesting sources of compounds with therapeutic and biotechnological potential.

Special attention will be paid to the interaction between the microbiome and host, host chemical defence strategies, the secretion and role of secondary metabolites, the secretion of antifouling chemicals and antibiotics, the extraction and identification of biomolecules, and seaweed disease control in aquaculture.

Prof. Nathalie Bourgougnon
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • marine seaweeds
  • marine invertebrates
  • microbiome
  • epibiosis
  • bacteria
  • fungi
  • virus
  • quorum sensing
  • holobiont
  • defence molecule
  • metagenomes
  • marine biotechnology

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop